Cargando…
Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
Despite the burden of disease of CVD and DM, there is a lack of experimentally validated literature exploring their association with exacerbation of COVID-19. Target receptors of medications commonly used to treat CVD and DM may be involved in the viral entry mechanism of SARS-CoV-2. We propose the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431108/ https://www.ncbi.nlm.nih.gov/pubmed/32838195 http://dx.doi.org/10.1007/s42399-020-00452-4 |